Age: 51.0
Sex: F
Vaccine: COVID19, TD
Symptoms: X-ray
Clinical narrative: My arm has just started to subside from the pain but has atrophied to/Pain did not start until almost a week after shots; My arm has just started to subside from the pain but has atrophied to; Lost full mobility of right upper arm to wrist/Cannot carry or hold anything and arm has lowered; Right arm muddle; arms without feeling; The initial case was missing the following minimum criteria: Unspecified product. Upon receipt of follow-up information on 30Jul2024, this case now contains all required information to be considered valid.  This is a spontaneous report and received from Consumer or other non HCPs, Program ID.  A 51-year-old female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 13May2024 as dose 1, single (Batch/Lot number: unknown) at the age of 51 years intramuscular for covid-19 immunisation; diphtheria vaccine toxoid, tetanus vaccine toxoid (TENIVAC), on 13May2024 as dose number unknown, single) intramuscular for onychoclasis. The patient's relevant medical history included: "Food Allergies" (unspecified if ongoing); "Seasonal Allergies" (unspecified if ongoing); "Allergies" (unspecified if ongoing); "prediabetes" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "flu like sickness" (unspecified if ongoing); "My right arm in the injection area cannot be used and is in tormented pain" (unspecified if ongoing); "broken toenail" (unspecified if ongoing). Concomitant medication(s) included: SINGULAIR taken for multiple allergies; CELEBREX taken for fibromyalgia; TIZANIDINE taken for fibromyalgia; LYRICA. The patient also took other concomitant therapy. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, unknown manufacturer), for COVID-19 immunisation. The following information was reported: PAIN IN EXTREMITY (disability), outcome "recovered with sequelae", described as "My arm has just started to subside from the pain but has atrophied to/Pain did not start until almost a week after shots"; ATROPHY (non-serious), outcome "unknown", described as "My arm has just started to subside from the pain but has atrophied to"; MOBILITY DECREASED (non-serious), outcome "unknown", described as "Lost full mobility of right upper arm to wrist/Cannot carry or hold anything and arm has lowered"; LIMB DISCOMFORT (non-serious), outcome "unknown", described as "Right arm muddle"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "arms without feeling". The events "my arm has just started to subside from the pain but has atrophied to/pain did not start until almost a week after shots", "my arm has just started to subside from the pain but has atrophied to", "lost full mobility of right upper arm to wrist/cannot carry or hold anything and arm has lowered", "right arm muddle" and "arms without feeling" required physician office visit. The patient underwent the following laboratory tests and procedures: X-ray: no damage. Clinical course: Patient went for a booster and added on a tetanus shot about a month ago. Her arm had just started to subside from the pain but has atrophied to where the only base level was to hold up as if a sling or cast. She had contacted her doctor's and (withheld) and nothing anyone could do. Name of the product(s) taken by the patient were Comirnaty 13May2024 Afternoon (withheld) 2nd shot of IM PVS Tenivac 0.5 ml as add or 1 m PFS (10 pace). Patent right arm in the injection area could not be used and was in tormented pain and requested a covid booster and tetanus. Patient phoned the pharmacy for antidote and her own doubts cured.  The information on the batch/lot number for BNT162b2 omi xbb.1.5 will be requested and submitted if and when received.